Raj Mehta

Raj Mehta is an accomplished entrepreneur and business leader in the biotechnology sector with extensive experience in founding and managing companies focused on innovative therapies for cancer and autoimmunity. Since October 2021, Raj Mehta has served as Founder, CEO, and Director of Adendra Therapeutics, translating dendritic cell biology into new treatments. Concurrently, Raj holds the position of Non-Executive Director at Revitope Oncology Inc. since January 2016, playing a crucial role in the company's strategic planning and funding initiatives. Notable past experiences include serving as Entrepreneur in Residence at Apple Tree Partners and holding key leadership roles at GammaDelta Therapeutics, including Interim CEO and Director of Business Development. With a robust background in business development and partnerships at Cancer Research Technology, Raj Mehta has successfully negotiated over 20 licensing agreements while managing a large portfolio of therapeutic projects. Raj Mehta’s educational foundation includes a BA in Natural Sciences from the University of Cambridge.